Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lisa Pleyer
Sidedness and TP53 Mutations Impact OS in Anti-Egfr but Not Anti-Vegf Treated mCRC - An Analysis of the KRAS Registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer
Nature
Multidisciplinary
Rationale Medikamentöse Tumortherapie
Der Urologe
Urology
Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules
Current Drug Metabolism
Clinical Biochemistry
Pharmacology
Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated With First-Line Tyrosine Kinase Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
First-Line Treatment in NSCLC Harboring EGFR Common Mutations: EGFR TKI in Monotherapy or in Combination With Anti-Vegf?
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Difficult but Not Impossible: In Search of an Anti-Candida Vaccine
Current Tropical Medicine Reports
Infectious Diseases
Allergy
Immunology
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Anti-Vegf Therapies in the Clinic
Cold Spring Harbor perspectives in medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Skin Toxicity Ant Anti-Egfr-Therapy: A Mock Trouble for Elderly and Frail Patients With McRc
Annals of Hematology & Oncology
